Company intelligence / Profile preview

Guangzhou Biotron Technology

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~130
Development stage: Other

Overview

Biotron has developed a suite of clinical diagnostic platforms with installed products in numerous institutions, over 70 patents, and broad deployment in China and abroad. Their main lines include POCT devices, molecular diagnostics, and immune detection solutions (no clinical trial data, as these are diagnostics, not therapeutics)

Therapeutic areas: OncologyInfectious DiseasesWomen's Health
Modalities: DeviceDiagnostic reagent
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Guangzhou Biotron Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Biotron Technology.

Explore the full profile